Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-06
2006-06-06
Kim, Vickie (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S317000, C514S423000, C514S330000, C514S422000, C514S548000
Reexamination Certificate
active
07056935
ABSTRACT:
This invention relates to methods of using neurotrophic compounds having an affinity for FKBP-type immunophilins to stimulate or promote neuronal growth or regeneration and to prevent neuronal degeneration.
REFERENCES:
patent: 2447587 (1948-08-01), Martin et al.
patent: 3312554 (1967-04-01), Wagner et al.
patent: 3370046 (1968-02-01), Wagner et al.
patent: 3396030 (1968-08-01), Haas
patent: 3452182 (1969-06-01), Haas
patent: 3713834 (1973-01-01), Fitzgerald
patent: 3810884 (1974-05-01), Gold
patent: 3833384 (1974-09-01), Noonan et al.
patent: 3879205 (1975-04-01), Fitzgerald et al.
patent: 3917840 (1975-11-01), Gold
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4154840 (1979-05-01), Ondetti et al.
patent: 4157418 (1979-06-01), Heilmann
patent: 4172934 (1979-10-01), Heilmann
patent: 4261895 (1981-04-01), Wiskott
patent: 4374829 (1983-02-01), Harris et al.
patent: 4401677 (1983-08-01), Greenberg et al.
patent: 4431644 (1984-02-01), Smith et al.
patent: 4439545 (1984-03-01), Aspisi et al.
patent: 4455366 (1984-06-01), Hirano et al.
patent: 4472380 (1984-09-01), Harris et al.
patent: 4474795 (1984-10-01), Greenberg et al.
patent: 4474799 (1984-10-01), Greenberg et al.
patent: 4633025 (1986-12-01), Corey
patent: 4650785 (1987-03-01), Toyoshima et al.
patent: 4668798 (1987-05-01), Kim
patent: 4668822 (1987-05-01), Corey
patent: 4670584 (1987-06-01), Toyoshima et al.
patent: 4766110 (1988-08-01), Ryan et al.
patent: 4808573 (1989-02-01), Gold et al.
patent: 4818749 (1989-04-01), Gold et al.
patent: 4898686 (1990-02-01), Johnson et al.
patent: 5002963 (1991-03-01), De Luca et al.
patent: 5128483 (1992-07-01), Trybulski et al.
patent: 5147877 (1992-09-01), Goulet
patent: 5192773 (1993-03-01), Armistead et al.
patent: 5227467 (1993-07-01), Durette et al.
patent: 5235066 (1993-08-01), Askin et al.
patent: 5252579 (1993-10-01), Skotnicki et al.
patent: 5321009 (1994-06-01), Baeder et al.
patent: 5330993 (1994-07-01), Armistead et al.
patent: 5385908 (1995-01-01), Nelson et al.
patent: 5385918 (1995-01-01), Connell et al.
patent: 5444042 (1995-08-01), Bartus et al.
patent: 5447915 (1995-09-01), Schreiber et al.
patent: 5453437 (1995-09-01), Schohe et al.
patent: 5516797 (1996-05-01), Armistead et al.
patent: 5527907 (1996-06-01), Or et al.
patent: 5530121 (1996-06-01), Kao et al.
patent: 5541189 (1996-07-01), Luly et al.
patent: 5541191 (1996-07-01), Skotnicki et al.
patent: 5541192 (1996-07-01), Skotnicki et al.
patent: 5543423 (1996-08-01), Zelle et al.
patent: 5589499 (1996-12-01), Weth
patent: 5599927 (1997-02-01), Or et al.
patent: 5604294 (1997-02-01), Luly et al.
patent: 5614547 (1997-03-01), Hamilton et al.
patent: 5620971 (1997-04-01), Armistead et al.
patent: 5621108 (1997-04-01), Smith, III et al.
patent: 5696135 (1997-12-01), Steiner
patent: 5795908 (1998-08-01), Hamilton
patent: 5798355 (1998-08-01), Steiner et al.
patent: 5801197 (1998-09-01), Steiner
patent: 5843960 (1998-12-01), Steiner
patent: 5846981 (1998-12-01), Steiner
patent: 5859031 (1999-01-01), Hamilton
patent: 5898029 (1999-04-01), Lyons et al.
patent: 6037370 (2000-03-01), Armistead
patent: 6124328 (2000-09-01), Armistead
patent: 879158 (1979-10-01), None
patent: 1102337 (1981-06-01), None
patent: 1103255 (1981-06-01), None
patent: 1103256 (1981-06-01), None
patent: 1103257 (1981-06-01), None
patent: 5 024 7/91 (1991-11-01), None
patent: 240379 (1945-12-01), None
patent: 86 1 01512 (1986-07-01), None
patent: 2 320 849 (1973-11-01), None
patent: 2 328 391 (1974-01-01), None
patent: 27 03 828 (1977-08-01), None
patent: 28 45 499 (1979-03-01), None
patent: 35 08 251 (1986-09-01), None
patent: 36 36 278 (1988-05-01), None
patent: 40 15 255 (1991-11-01), None
patent: 44 25 950 (1996-01-01), None
patent: 0 012 401 (1980-06-01), None
patent: 0 038 117 (1981-10-01), None
patent: 0 048 159 (1982-03-01), None
patent: 0 050 800 (1982-05-01), None
patent: 0 088 350 (1983-09-01), None
patent: 0 093 551 (1983-11-01), None
patent: 0 182 523 (1986-05-01), None
patent: 0 187 547 (1986-07-01), None
patent: 0 196 841 (1986-10-01), None
patent: 0 198 348 (1986-10-01), None
patent: 0 198 352 (1986-10-01), None
patent: 0 309 766 (1989-04-01), None
patent: 0 378 318 (1990-07-01), None
patent: 0 405 994 (1991-01-01), None
patent: 0 564 924 (1993-10-01), None
patent: 1533817 (1968-07-01), None
patent: 2 010 601 (1970-02-01), None
patent: 2 407 204 (1978-10-01), None
patent: 2 167 075 (1986-05-01), None
patent: 2 247 456 (1992-03-01), None
patent: 57-16809 (1982-01-01), None
patent: 63-200060 (1988-08-01), None
patent: WO 88/09789 (1988-12-01), None
patent: WO 91/13088 (1991-09-01), None
patent: WO 92/00278 (1992-01-01), None
patent: WO 92/04370 (1992-03-01), None
patent: WO 92/18478 (1992-10-01), None
patent: WO 92/19593 (1992-11-01), None
patent: WO 92/19745 (1992-11-01), None
patent: WO 92/21313 (1992-12-01), None
patent: WO 93/07269 (1993-04-01), None
patent: WO 93/23548 (1993-11-01), None
patent: WO 93/25546 (1993-12-01), None
patent: WO 94/07858 (1994-04-01), None
patent: WO 95/26337 (1995-10-01), None
patent: WO 96/06097 (1996-02-01), None
US 5,654,332, 08/1997, Armistead (withdrawn)
Holt et al., “Structure-Activity Studies of Synthetic FKBP Ligands as Peptidyl-prolyl Isomerase Inhibitors”, Bioorganic and Medicinal Chemistry Letters, vol. 4, No. 2, pp. 315-320, 1994.
Yamashita et al., “Design, Synthesis and Evaluation of Dual Domain FKBP Lignads”, Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 2, pp. 325-328, 1994.
Yamamoto et al., “Stimulation of Hair Growth by Topical Application of FK506, a Potent Immunosuppressive Agent”, Journal of Investigative Dermatology, vol. 102, No. 2, pp. 160-164, 1994.
Wang et al., “Synthesis and FKBP Binding of Small Molecule Mimics of the Tricarbonyl Region on FK506”, Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 9, pp. 1161-1166, 1994.
Steffan et al., “Base Catalyzed Degradations of Rapamycin”, Tetrahedron Letters, vol. 34, No. 23, pp. 3699-3702, 1993.
Steiner et al., “High Brain Densities of the Immunophilin FKBP Colocalized with Calcineurin”, Nature, vol. 358, pp. 584-586, 1992.
Stocks et al., “Marcrocyclic Ring Closures Employing the Intramolecular Heck Reaction”, Tetrahedron Letters, vol. 36, No. 36, pp. 6555-6558, 1995.
Stocks et al., “The Contribution to Binding of the Pyranoside Substituents in the Excised Binding Domain of FK-506,”, Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 12, pp. 1457-1460, 1994.
Tanaka et al., “Structure of FK506: A Novel Immunosuppressant Isolated from Streptomyces”, J. Am. Chem. Soc., 109, pp. 5031-5033, 1987.
Tatlock et al., “High Affinity FKBP-12 Ligands Derived from (R)-(-)-Carvone. Synthesis and Evaluation of FK506 Pyranose Ring Replacements”, Bioorganic & Medicinal Chemistry Letters, vol. 5, No. 21, pp. 2489-2494, 1995.
Teague et al., “The Affinity of the Excised Binding Domain of FK-506 for the Immunophilin FKBP12”, Bioorganic & Medicinal Chemistry Letters, vol. 3, No. 10, pp. 1947-1950, 1993.
Teague et al., “Synthesis of FK506-Cyclosporin Hybrid Macrocycles”, Bioorganic & Medicinal Chemistry Letters, vol. 5, No. 20, pp. 2341-2346, 1995.
Teague et al., “Synthesis and Study of a Non Macrocyclic FK506 Derivative”, Bioorganic & Medicinal Chemistry Letters, vol. 4, No. 13, pp. 1581-1584, 1994.
Tindall, “Immunointervention with Cyclosporin A in Autoimmune Neurological Disorders”, Journal of Autoimmunity, vol. 5 (Supp. A), pp. 301-313, 1992.
Tugwell, “Cyclosporin in the Treatment of Rheumatoid Arthritis”, Journal of Autoimmunity, vol. 5 (Supp. A), pp. 231, 240, 1992.
Snyder et al., “Immunophilins and the Nervous System”, Nature Medicine, vol. 1, No. 1, pp. 32-37, 1995.
Nakatsuka et al., “Total Synthesis of FK506 and an FKBP Probe Reagent, (C8, C9-13C2)-FK506”, J. Am. Chem. Soc., vol. 112, No. 14, pp. 5583-5601, 1990.
Nelson et al., “A Novel Ring Contraction of
Hamilton Gregory S.
Steiner Joseph P.
Foley & Lardner LLP
GPI NIL Holdings Inc.
Kim Vickie
LandOfFree
Rotamase enzyme activity inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rotamase enzyme activity inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rotamase enzyme activity inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685588